Andere Kunden interessierten sich auch für
![CNS Neuroprotection]( "CNS Neuroprotection")
CNS Neuroprotection233,99 €![Serotoninergic Neurons and 5-HT Receptors in the CNS]( "Serotoninergic Neurons and 5-HT Receptors in the CNS")
Serotoninergic Neurons and 5-HT Receptors in the CNS39,99 €![CNS Neuroprotection]( "CNS Neuroprotection")
CNS Neuroprotection229,99 €![The Glutamate Synapse as a Therapeutic Target]( "The Glutamate Synapse as a Therapeutic Target")
The Glutamate Synapse as a Therapeutic Target250,99 €![Drug Design and Discovery in Alzheimer's Disease]( "Drug Design and Discovery in Alzheimer's Disease")
Drug Design and Discovery in Alzheimer's Disease69,99 €![Drug Dependence and Emotional Behavior]( "Drug Dependence and Emotional Behavior")
Drug Dependence and Emotional Behavior109,99 €![Rational Basis for Clinical Translation in Stroke Therapy]( "Rational Basis for Clinical Translation in Stroke Therapy")
Rational Basis for Clinical Translation in Stroke Therapy273,99 €
- History and biology of erythropoietin in hematopoietic system and tissues other than nervous system
- Expression of erythropoietin and its receptor in the central nervous system
- Erythropoietin and neuroprotection in the Central Nervous System
- Regulation of Erythropoietin expression in the nervous system
- Erythropoietin in the developing brain
- Erythropoietin for the treatment of Acute Ischemic Stroke
- Erythropoietin protects retinal ganglion cells against ischemia and axotomy-induced neuronal death
- Erythropoietin for treatment of human brain disease
- Erythropoietin and the Spinal Cord Injury
- Erythropoietin and neuroprotection in the Peripheral Nervous System
- An endogenous neuroprotective pathway in the peripheral nervous system mediated by Schwann cell - derived erythropoietin
- Role of erythropoietin in inflammatory pathologies of the CNS
- Development of non-erythropoietic erythropoietin variants for neuroprotection.
Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This is the first book of its kind that brings together researchers from many different disciplines of neuroscience to review the current state-of-the-art in EPO and the nervous system. This book will benefit scientists and clinicians interested in neuroprotection in the broadest sense.
- Expression of erythropoietin and its receptor in the central nervous system
- Erythropoietin and neuroprotection in the Central Nervous System
- Regulation of Erythropoietin expression in the nervous system
- Erythropoietin in the developing brain
- Erythropoietin for the treatment of Acute Ischemic Stroke
- Erythropoietin protects retinal ganglion cells against ischemia and axotomy-induced neuronal death
- Erythropoietin for treatment of human brain disease
- Erythropoietin and the Spinal Cord Injury
- Erythropoietin and neuroprotection in the Peripheral Nervous System
- An endogenous neuroprotective pathway in the peripheral nervous system mediated by Schwann cell - derived erythropoietin
- Role of erythropoietin in inflammatory pathologies of the CNS
- Development of non-erythropoietic erythropoietin variants for neuroprotection.
Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This is the first book of its kind that brings together researchers from many different disciplines of neuroscience to review the current state-of-the-art in EPO and the nervous system. This book will benefit scientists and clinicians interested in neuroprotection in the broadest sense.